Page last updated: 2024-11-02

1,2-cyclohexanediamine and Neoplasms

1,2-cyclohexanediamine has been researched along with Neoplasms in 4 studies

1,2-cyclohexanediamine: RN given refers to cpd without isomeric designation

Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Research Excerpts

ExcerptRelevanceReference
"Eight platinum(II) complexes with anticancer potential have been synthesised and characterised."1.40Synthesis and analysis of the anticancer activity of platinum(II) complexes incorporating dipyridoquinoxaline variants. ( Aldrich-Wright, JR; Ang, DL; Clegg, JK; Danchaiwijit, S; Kepert, CJ; Li, F; Pages, BJ; Spare, LK; Wormell, P, 2014)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Sancho-Albero, M1
Facchetti, G1
Panini, N1
Meroni, M1
Bello, E1
Rimoldi, I1
Zucchetti, M1
Frapolli, R1
De Cola, L1
Liu, W1
Ye, Q1
Jiang, J1
Lou, L1
Xu, Y1
Xie, C1
Xie, M1
Pages, BJ1
Li, F1
Wormell, P1
Ang, DL1
Clegg, JK1
Kepert, CJ1
Spare, LK1
Danchaiwijit, S1
Aldrich-Wright, JR1
Kidani, Y1

Other Studies

4 other studies available for 1,2-cyclohexanediamine and Neoplasms

ArticleYear
Enhancing Pt(IV) Complexes' Anticancer Activity upon Encapsulation in Stimuli-Responsive Nanocages.
    Advanced healthcare materials, 2023, Volume: 12, Issue:17

    Topics: Animals; Antineoplastic Agents; Mesothelioma, Malignant; Mice; Neoplasms; Organoplatinum Compounds

2023
cis-[Pt(II) (1R,2R-DACH)(3-acetoxy-1,1-cyclobutanedicarboxylato)], a water-soluble, oxalate-free and stable analogue of oxaliplatin: synthesis, characterization, and biological evaluations.
    ChemMedChem, 2013, Volume: 8, Issue:9

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Coordination Complexes; Crystallography, X-R

2013
Synthesis and analysis of the anticancer activity of platinum(II) complexes incorporating dipyridoquinoxaline variants.
    Dalton transactions (Cambridge, England : 2003), 2014, Nov-07, Volume: 43, Issue:41

    Topics: Animals; Antineoplastic Agents; Cattle; Cell Line, Tumor; Crystallography, X-Ray; Cyclohexylamines;

2014
[Development of antitumor platinum complexes].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1983, Volume: 10, Issue:12

    Topics: Animals; Antineoplastic Agents; Carboplatin; Cisplatin; Cyclohexylamines; Humans; Kidney; Neoplasms;

1983